The Role of Imaging Data from Different Radiologic Modalities During the Previous Global Pandemic

Abstract

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed unprecedented challenges to the medical community, particularly in the field of imaging. The multifaceted nature of COVID-19, affecting various organs and systems, necessitates a comprehensive understanding of its imaging characteristics to enhance diagnosis, management, and prognosis. This paper provides an extensive review of the imaging findings associated with COVID-19, focusing on cardiothoracic, neurological, and other system involvements. We delve into the roles of different imaging modalities, including chest radiography, computed tomography (CT), magnetic resonance imaging (MRI), and echocardiography, and highlight the significance of these findings in clinical practice. Furthermore, we discuss the implications of long-term sequelae and the evolving role of imaging in the context of post-acute sequelae of SARS-CoV-2 infection (PASC).

References

 

[1] Ghasemi Y, Afrazeh F, Shomalzadeh M, Rostamian S, Abbasi H. Recent updates on the safety of neurosurgery during the COVID-19 pandemic. World Journal of Biology Pharmacy and Health Sciences. 2024;19(1):018-23. https://doi.org/10.30574/wjbphs.2024.19.1.0389

[2] Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak what we know. International Journal of Infectious Diseases. 2020.

[3] Mao L, Jin H, Wang M, Hu Y, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurology. 2020.

[4] Vollono C, Rollo E, Romozzi M, et al. Focal status epilepticus as a unique clinical feature of COVID-19: a case report. Seizure. 2020.

[5] Vu D, Ruggiero M, Choi WS. Three unsuspected CT diagnoses of COVID-19. Emergency Radiology. 2020:1–4.

[6] Singhania N, Bansal S, Singhania G. An Atypical Presentation of Novel Coronavirus Disease 2019 (COVID-19). The American Journal of Medicine. 2020.

[7] Khoshnood RJ, Ommi D, Zali A, Ashrafi F, Vahidi M, Azhide A, Shirini D, Sanadgol G, Khave LJ, Nohesara S, Nematollahi S. Epidemiological characteristics, clinical features, and outcome of COVID-19 patients in northern Tehran, Iran; a cross-sectional study. Frontiers in Emergency Medicine. 2021;5(1):e11-.

[8] Radpour A, Bahrami-Motlagh H, Taaghi MT, Sedaghat A, Karimi MA, Hekmatnia A, Haghighatkhah HR, Sanei-Taheri M, Arab-Ahmadi M, Azhideh A. COVID-19 evaluation by low-dose high-resolution CT scans protocol. Academic radiology. 2020 Jun;27(6):901.

[9] World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV).

[10] Azhideh A. COVID-19 neurological manifestations. International Clinical Neuroscience Journal. 2020 Mar 10;7(2):54-.

[11] Tsai LK, Hsieh ST, Chao CC, Chen YC, Lin YH, Chang SC, et al. Neuromuscular disorders in severe acute respiratory syndrome. Archives of Neurology. 2004;61(11):1669–1673.

[12] Azhideh A, Menbari-Oskouie I, Yousefi-Asl M. Neurological manifestation of COVID-19: a literature review. Int Clin Neurosci J. 2020 Jan 1;7(4):164-70.

[13] Lau KK, Yu WC, Chu CM, Lau ST, Sheng B, Yuen KY. Possible central ner-vous system infection by SARS coronavirus. Emerging infectious diseases.2004;10(2):342.

[14] Salmi A, Ziola B, Hovi T, Reunanen M. Antibodies to coronaviruses OC43 and229E in multiple sclerosis patients. Neurology. 1982;32(3):292.

[15] Ashrafi F, Zali A, Ommi D, Salari M, Fatemi A, Arab-Ahmadi M, Behnam B, Azhideh A, Vahidi M, Yousefi-Asl M, Jalili Khoshnood R. COVID-19-related strokes in adults below 55 years of age: a case series. Neurological Sciences. 2020 Aug;41:1985-9.

[16] Sedaghat A, Gity M, Radpour A, Karimi MA, Haghighatkhah HR, Keshavarz E, Hekmatnia A, Arab-Ahmadi M, Sanei-Taheri M, Azhideh A. COVID-19 protection guidelines in outpatient medical imaging centers. Academic radiology. 2020 Jun;27(6):904.

[17] National Heart, Lung, and Blood Institute website. Study quality assessment tools. www.nhlbi.nih. gov/health-topics/study-quality-assessment-tools.

[18] Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19 systematic review. Journal of the Neurological Sciences. 2020:116832.

[19] Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis Research. 2020.

[20] Karimi N, Sharifi Razavi A, Rouhani N. Frequent Convulsive Seizures in an Adult Patient with COVID-19: A Case Report. Iranian Red Crescent Medical Journal.2020.

[21] Moriguchi T, Harii N, Goto J, et al. A first Case of Meningitis/Encephalitis associated with SARS-Coronavirus-2. International Journal of Infectious Diseases. 2020.

[22] Kandemirli SG, Dogan L, Sarikaya ZT, et al. Findings in Patients in the Intensive Care Unit with COVID-19 Infection [published online ahead of print, 2020 May]. Radiology. 2020:201697.

[23] Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020;12(3).

[24] Herrnberger M, Durmazel N, Birklein F. Hemisensory paresthesia as the initial symptom of a SARS-Coronavirus-2 infection. A Case Report. Preprint. Doi:10.21203/rs.3.rs-26305/v1.

[25] Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain, behavior, and immunity. 2020.

[26] Andrea G, Vinacci G, Edoardo A, Anna M, Fabio B. Neuroradiological features in COVID-19 patients: first evidence in a complex scenario. Journal of Neuroradiology. 2020.

[27] Penninx BW, Benros ME, Klein RS, Vinkers CH. How COVID-19 shaped mental health: from infection to pandemic effects. Nature medicine. 2022 Oct;28(10):2027-37.